More tools:
Markets
·
Screener
·
Research
·
Chat
ELOXX PHARMACEUTICALS INC (ELOX) Financial Statements
ELOXX PHARMACEUTICALS INC
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG001S799Q4
OTC Link · usd
16.57
▲ 0.40 (2.47%)
As of 2026-09-09
1M
6M
1Y
Valuation
Market Cap
$66.9M
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
—
EBITDA
—
Diluted EPS (TTM)
—
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
16.17
Day's Range
15.16 – 17.74
52-Week Range
0.02 – 23.40
Volume
37.4K
Avg Volume
55.0K
Share Statistics
Shares Outstanding
4.0M
Employees
—
Exchange
OTC Link
Listed
—
Share count as of August 7, 2026
View
Income Statement
Balance Sheet
Cash Flow
Key Metrics
Valuation
Comparable Companies
Notes & Facts
DCF Model
Earnings Calls
Guidance
Presentations
Detail
Standard
Detailed
Period
Annual
Quarterly
TTM
Loading Income Statement…
Key questions about ELOXX PHARMACEUTICALS INC (ELOX)
What is ELOXX PHARMACEUTICALS INC's Market Cap?
ELOXX PHARMACEUTICALS INC's Market Cap is $66.9M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Subscribe
Income Statement
(in thousands of USD, except per-share data)
Source: Akyla.ai
Line Item
Jun 30, 2026
Jun 30, 2025
Operating expenses:
Research and development
2,840.0
General and administrative
1,610.0
Total operating expenses
4,450.0
Loss from operations
(4,450.0)
Other expense, net
52.0
Net loss
(4,502.0)
Net loss per share, basic
(0.66)
Net loss per share, diluted
(0.66)